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ABSTRACT
Haemophilus influenzae is the most common cause of bacterial infection in the lungs of chronic
obstructive pulmonary disease (COPD) patients and contributes to episodes of acute exacerba-
tion which are associated with increased hospitalization and mortality. Due to the ability of
H. influenzae to adhere to host epithelial cells, initial colonization of the lower airways can pro-
gress to a persistent infection and biofilm formation. This is characterized by changes in bacterial
behaviour such as reduced cellular metabolism and the production of an obstructive extracellular
matrix (ECM). Herein we discuss the multiple mechanisms by which H. influenzae contributes to
the pathogenesis of COPD. In particular, mechanisms that facilitate bacterial adherence to host
airway epithelial cells, biofilm formation, and microbial persistence through immune system eva-
sion and antibiotic tolerance will be discussed.
ARTICLE HISTORY
Received 28 September 2020
Revised 4 December 2020
Accepted 7 December 2020







Chronic obstructive pulmonary disease (COPD) is a pro-
gressive but preventable condition associated with loss
of lung function due to prolonged exposure to noxious
particles or gases (Vogelmeier et al. 2017). It is typically
characterized by airway obstruction as a consequence
of small airway disease and parenchymal destruction in
varying proportions (Rabe and Watz 2017).
An increase in disease severity is linked to a greater
frequency of events associated with a sudden decline
in lung function, known as an acute exacerbation of
COPD (AECOPD) (Vogelmeier et al. 2017). These hetero-
geneous events, caused by interactions between patho-
gens, the lung environment, and the associated host
response, lead to an increase in airway inflammation
and a worsening of clinical symptoms (Sapey and
Stockley 2006; Sethi and Murphy 2008). The disrupted
innate lung defences observed in patients with COPD
contribute to an increased frequency of airway infec-
tions making the patient more susceptible to AECOPD
(Sethi 2010). Knowledge of the nature of the inflamma-
tory changes within the airways during exacerbations
is, however, limited due to the relative risks involved in
carrying out bronchial biopsies in patients with moder-
ate or severe COPD (Hattotuwa et al. 2002).
Viruses are detected in approximately 50% of COPD
exacerbations (Seemungal et al. 2001; Rohde et al.
2003), but an association between exacerbations and
bacterial infections is more difficult to assess. This is
because, in addition to acute bacterial infections driving
the acquisition of AECOPD, the airways of COPD
patients are intermittently colonized by pathogenic
bacteria, with bacteria present at both stable and peri-
ods of exacerbation. Molecular science techniques, such
as strain typing, allow specific bacterial strains to be iso-
lated from patients and have provided evidence that
the acquisition of new bacterial strains is a key trigger
for an exacerbation (Sethi et al. 2002; Veeramachaneni
and Sethi 2006). The associated, inappropriately ele-
vated, inflammatory response (Sethi and Murphy 2008)
is then driven by the higher levels of immune cells
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present in COPD airways such as macrophages, neutro-
phils, eosinophils, and dendritic cells (Di Stefano et al.
1994; Van Pottelberge et al. 2010; Barnes 2014; Finney
et al. 2014).
Of all the bacterial strains capable of colonizing the
respiratory tract of COPD patients, Haemophilus influenzae
is arguably the most clinically relevant. Non-typeable H.
influenzae (NTHi) is frequently isolated from COPD patients
(Sethi et al. 2002) and is associated with up to 30% of
acute exacerbations (Sethi 2010). Additionally, NTHi is
detected in 30% of COPD patients during stable disease
over extended periods of time (Patel et al. 2002; Wilkinson
et al. 2003; Marin et al. 2010). This indicates that NTHi uti-
lizes a number of mechanisms in the airways that sur-
mount innate and adaptive host defences as well as
antibiotic treatments. This review will summarise the cur-
rent understanding of H. influenzae biofilm formation and
other mechanisms employed to enable its persistence
within the COPD lung environment.
Haemophilus influenzae
H. influenzae is a human-restricted, Gram-negative coc-
cobacillus that exists as a commensal organism within
the nasopharyngeal flora of most humans (Erwin and
Smith 2007). When growing aerobically, H. influenzae
requires the presence of haemin and nicotinamide
adenine dinucleotide (NAD; factors X and V, respect-
ively) (Artman et al. 1983). Strains of H. influenzae are
classified based on the presence, or absence of a chem-
ically distinct polysaccharide capsule, which is divided
into six serotypes (a–f) (Falla et al. 1994). Strains lacking
a polysaccharide capsule are designated as NTHi.
As well as being a major cause of AECOPD, H. influenzae
has been implicated in other conditions such as the
inflammatory disease of the middle ear, otitis media
(OM), and pneumonia (Gilsdorf et al. 2004). H. influen-
zae normally spread from person to person by inhal-
ation of respiratory droplets or through direct contact
of respiratory secretions (King 2012). H. influenzae
serotype b (Hib) strains cause invasive infections in
infants and children but since the development of the
Hib conjugate vaccine, infection by H. influenzae is
predominately due to NTHi (Van Eldere et al. 2014;
Zarei et al. 2016). NTHi strains commonly colonize the
upper respiratory tract and cause mucosal infections
in children and adults (Agrawal and Murphy 2011).
Initial adherence of NTHi to the COPD airway
The first step in the timeline of bacterial infection is the
initial adhesion to the host. As a respiratory pathogen,
NTHi must, however, first overcome the primary innate
defences of the mucociliary escalator before attach-
ment to the airway epithelium can occur (Ganesan
et al. 2013). Effective mucociliary clearance (MCC) is
dependent on the regulation of an optimal airways sur-
face liquid by apical plasma membrane ion channels,
ciliary beating, and appropriate levels of mucin secre-
tion (Figure 1(A)); however, these can all be dysregu-
lated in COPD (Figure 1(B)) (Ghosh et al. 2015).
Cigarette smoke exposure, a common cause of
COPD, decreases the activity of the cystic fibrosis trans-
membrane conductance regulator (CFTR; a cAMP-
dependent chloride channel), which leads to airways
dehydration (Clunes et al. 2012). Cigarette smoke
exposure is also associated with a decrease in ciliary
beat frequency (Yaghi et al. 2012), with lipooligosac-
charide present in the cell wall of NTHi and protein D
shown to further inhibit ciliary function (Denny 1974;
Johnson and Inzana 1986; Janson et al. 1999). Airway
mucus hypersecretion is also recognized as a key
physiological feature of COPD (Rogers and Barnes
2006). This combination of thick, dehydrated mucous
secretions and a decreased ciliary beat frequency
severely disrupts MCC facilitating colonization of the
airways by bacteria such as NTHi (King 2012) (Figure 1).
NTHi subsequently uses a number of specialised cell
surface proteins (summarised in Figure 2) to adhere to
and invade the respiratory mucosa, enabling escape
from host cellular immune defences.
The type IV pili (T4P), regulated by the products of
the pilA and comE genes, are composed of helically
arranged pilin subunits that form filamentous polymer
assemblies. Their presence on the surface of a number
of Gram-negative bacteria facilitates the uptake of DNA
across the bacterial cell membrane, mediates adherence
to mammalian epithelial cells and promotes genetic
adaptability which also contributes to biofilm formation
(Jurcisek et al. 2007). T4P exhibits high levels of adher-
ence to the Intracellular Adhesion Molecule-1 (ICAM-1)
which promotes epithelial cell adherence (Figure 2(A)).
ICAM-1 is an adhesion molecule that is part of the
immunoglobulin superfamily. It facilitates reversible
adhesion and signal transduction between cells but in
airways, cells are also exploited by a number of bacter-
ial and viral pathogens such as NTHi and rhinovirus to
enable their own adhesion and uptake.
ICAM-1 is present on the surface of a number of dif-
ferent cell types including airway epithelial cells (AECs)
at a basal level but is increased following exposure to
cigarette smoke (Scott and Palmer 2003). Increased lev-
els of ICAM-1 are also observed in AECs of smokers and
COPD patients (Shukla et al. 2017). Exposure to NTHi
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can increase the expression of its receptor in AECs
through upregulation of ICAM-1 (Avadhanula et al.
2006). The presence of further attachment points on
the surface of AECs then act as a positive feedback loop
for attachment and infection by NTHi. The P1 fimbriae
bind to the carcinoembryonic antigen-related cell adhe-
sion molecule 1 (CEACAM-1) cell surface glycoprotein
present on the surface of epithelial cells (Tchoupa et al.
2015), whereas the P5 fimbriae facilitate cellular adhe-
sion via mucins, CEACAM-1 and ICAM-1 (Avadhanula
et al. 2006). Additionally, the NTHi high molecular
weight adhesins Hmw1 and Hmw2 are key glycopro-
teins that display high levels of homology and are also
key proteins in the process of binding to respiratory
epithelial cells (Geme and Yeo 2009; Rempe et al. 2016).
Expression of both Hmw1 and Hmw2 are associated
with invasive and virulent strains of H. influenzae
(Vuong et al. 2013). In addition to Hmw proteins,
H. influenzae possesses proteins that mediate adhesion
to epithelial cells. Using dual RNA-sequencing, Baddal
et al. (2015) identified the upregulation of multiple viru-
lence factors, which included the gene encoding
H. influenzae adhesion (Hia), another cell surface adhe-
sion molecule found to mediate adherence to AECs
(Spahich and St Geme 2011).
NTHi also utilizes the exposed extracellular matrix
(ECM) present within the COPD airway environment to
facilitate attachment by Haemophilus adhesion protein
Figure 1. Summary of pathophysiological changes to the airway epithelium in COPD patients leading to an increased frequency
of infections. (A) Healthy airway epithelium showing optimal airway hydration and effective mucociliary clearance. (B) COPD air-
way epithelium showing a reduction in the level of airway hydration through decreased Cl release by cystic fibrosis transmem-
brane conductance regulator (CFTR) ion channels, present on the apical surface of ciliated airway epithelial cells. Exposure to
cigarette smoke and lipopoligosaccharide and protein D from non-typeable Haemophilus influenzae (NTHi) lead to a decrease in
ciliary beat frequency. Mucus hypersecretion is also observed in COPD airways. These changes lead to the accumulation of thick
mucus that is not easily expelled from the airway, disrupting mucociliary clearance and facilitating initial bacterial adherence to
the airway. Exposed sections of the basement membrane also facilitate adhesion of NTHi to extracellular matrix components pre-
sent in the basement membrane. Created with BioRender.com.
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(HAP) (Fink et al. 2002; Houghton et al. 2006) (Figure
2(B)). HAP is a ubiquitously expressed adhesion protein
that binds to basement membrane components such
as fibronectin, laminin, and collagen IV (Fink et al. 2002;
De Chiara et al. 2014; Sekiguchi and Yamada 2018).
HAP, however, is not required for biofilm formation
(Hendrixson and St Geme 1998). Additionally, the P4
adhesion fimbrae adheres to fibronectin, laminin, and
vitronectin and, as with P1, P2, and P5, are present in
biofilms (Murphy and Kirkham 2002; Wu et al. 2014a; Su
et al. 2016). Protein E (PE) of NTHi is involved in adhe-
sion and activation of epithelial cells (Singh et al. 2010),
interacts with laminin and vitronectin present within
the ECM (Hallstrom et al. 2011), and upregulates IL-8
and ICAM-1 expression in AECs (Singh et al. 2013).
H. influenzae fimbriae (HiF) bind to mucins (Kubiet
et al. 2000). In COPD mucus hypersecretion and defect-
ive MCC provide a relatively static mucin-rich environ-
ment which facilitates the adherence of HiF (along with
the P5 Fimbriae) (Figure 2(C)). PE is also involved in
evading host defences by binding to the proenzyme
plasminogen causing its catalytic conversion to plasmin
(Osman et al. 2018), a serine protease which, in addition
to its primary role in fibrinolysis, has been shown to
inhibit the complement pathway. The adhesion mole-
cules described above, facilitate initial adhesion to AECs
and also highlight the adaptations that allow HTHi to
exploit the damaged, chronically inflamed environment
present in the airways of COPD patients. Although
adhesion to the airways facilitates infection, it is also
the critical first step in the formation of a biofilm (Rabin
et al. 2015).
NTHi biofilms and bacterial persistence
A widely utilized mechanism of bacterial persistence
within the respiratory tract is the formation of biofilms
(Murphy and Kirkham 2002; Murphy et al. 2004; 2005).
Biofilms are described as a community of cells encased
in a self-produced ECM, adhered to a biotic or abiotic
surface (Lopez et al. 2010). In the airways, biofilms may
act as reservoirs of bacteria, which can trigger the
reoccurrence of lower respiratory infections and con-
tribute to frequent exacerbator phenotypes in COPD
(Sethi 2010). They are characterized by changes in cell
behaviour, such as differential gene expression and
ECM production which, in turn, can lead to increased
virulence, antimicrobial tolerance and decreased sus-
ceptibility to killing from immune cells (Singh et al.
2017) (Figure 3). Biofilms also differ significantly in
structure within the lungs. Instead of forming the
“traditional” mushroom-like structure, they take on a
small aggregate phenotype (Darch et al. 2018). These
aggregates contain between 101 and 104 cells whilst
retaining biofilm-associated characteristics such as
increased antimicrobial tolerance.
Haemophilus influenzae biofilm formation
Using a multi-omics approach, Harrison et al. (2019)
characterized the transcriptome, metabolome, and
proteome of H. influenzae to identify the driving forces
behind its biofilm formation. Significant increases in
amino acids and enzymes involved in central metabolic
processes such as serine and glycine were identified,
along with increases in adhesin production in combin-
ation with enriched DNA metabolism pathways.
Figure 2. Summary of the roles of adhesion molecules present in strains of non-typeable Haemophilus influenzae (NTHi).
(A) Interactions of P1 and P5 adhesins as well as the type IV pili with cell surface glycoproteins CEACAM-1 and ICAM-1 to facili-
tate adherence to the surface of airway epithelial cells; (B) highlights the roles of the HAP, P4 adhesin and PE in the adherence
of NTHi to components of the basement membrane present in the airways, and (C) shows the adhesion of HiF and the P5 fim-
briae to mucins present in the mucus secreted in the airway as well as the enzymatic conversion of plasminogen to plasmin by
PE to disrupt the complement cascade. Created with BioRender.com.
CRITICAL REVIEWS IN MICROBIOLOGY 195
Another interesting observation from the same study
was a significant increase in the expression of an
uncharacterized ATP-binding cassette (ABC) periplasmic
protein. Many members of this protein family provide
bacteria with multi-drug resistance (Wilkens 2015)
therefore, the increased expression of these pathways
has been hypothesized to increase H. influenzae survival
in vivo through contribution to horizontal gene transfer
throughout the biofilms.
Biofilm communities have been studied in vitro for
decades but it is extremely difficult to properly mimic
in vivo conditions such as host immune responses and
nutrient availability (Bjarnsholt et al. 2013). Biofilms
formed by H. influenzae in vivo can, therefore, differ
greatly from those formed in vitro (Brown et al. 2019b).
From analyzing images of in vivo H. influenzae biofilms
formed on the middle ear of chinchillas, Brown et al.
(2019b) developed a reproducible, in silico, agent-based
model to simulate biofilm formation in vivo. Results of
this model showed that H. influenzae biofilms in vivo
are formed following a similar spatial distribution pat-
tern to their in vitro counterparts. However, in vivo bio-
films were more than 10-fold smaller, likely as a result
of host factors clearing planktonic and poorly inte-
grated biofilm cells. These data highlight the import-
ance of closely replicating host environments when
studying biofilms in disease pathogenesis and provide
a strong foothold to apply a similar approach to
H. influenzae biofilms in the respiratory tract. Doing so
would be crucial in accurately studying H. influenzae
biofilm pathogenesis in COPD.
Epithelial cell attachment
As previously discussed, adhesion proteins of H. influen-
zae play a key role in the attachment of the bacteria to
epithelial cells which is the first step in the formation of
biofilms. Indeed, it appears that H. influenzae increases
adhesin protein production in response to contact with
human respiratory epithelium as evident in co-cultures
where the expression of T4P is significantly increased
within 30min following exposure (Mokrzan et al. 2019).
In agreement with these findings, Baddal (2020)
showed that H. influenzae adhesion to bronchial Calu-3
cells increased in a time-dependent manner, up to 72 h,
at which point the colonizing bacterial cells were also
found to induce epithelial cell apoptosis.
Quorum sensing
In many species of bacteria, proper biofilm develop-
ment is dependent on the release and uptake of dens-
ity-dependent small molecules, known as quorum
sensing (Miller and Bassler 2001). In biofilms, quorum
sensing pathways can regulate development, whereas
others can induce or promote biofilm dispersal. One
such quorum sensing network is the auto-inducer 2
(AI-2) pathway which is controlled by the luxS operon.
Utilizing an H. influenzae mutant, where the luxS operon
was controlled by the xylA promoter (which is activated
Figure 3. Haemophilus influenzae biofilms interact with the host and antibiotics. H. influenzae biofilms utilize a number of mecha-
nisms to persist in the host. Production of a robust ECM aids in the resistance to neutrophils and NETS (1) and IgA proteases on
the matrix surface cleave IgA (2). The thick ECM also prevents phagocytosis by blocking macrophage access to biofilm cells (3),
pairing this with lowered cell metabolism and protein synthesis the activity of antibiotics (4) on biofilm cells is minimal. Another
important mechanism of resistance is eDNA that is incorporated into the biofilm matrix that binds b-defensin (5), reducing its
antimicrobial properties. Finally, likely as a stress response, b-lactam antibiotics induce biofilm formation in H. influenzae (6). Flat
headed arrows indicate an inhibitory effect whereas pointed arrows indicate a stimulatory effect. Created with BioRender.com.
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in the presence of xylose), Pang et al. (2018) showed
that luxS operon activation and interruption influenced
biofilm maturation and dispersal, respectively.
Induction of luxS synthesis also resulted in increased
transcription of a glycosyltransferase enzyme. In other
bacterial biofilms formed by streptococcal species,
which are also frequently identified in the lungs of
COPD patients, glycosyltransferases are key enzymes
involved in the production of biofilm ECM (Souza
et al. 2020).
Extracellular DNA
Additional key components of H. influenzae biofilms
released into the surrounding area, with multiple crucial
roles, are extracellular DNA (eDNA) and DNABII proteins
(Marti et al. 2017; Devaraj et al. 2018). H. influenzae
DcomE strains fail to secrete both proteins. H. influenzae
T4P is also expressed through the pore formed by the
comE product (Das et al. 2017; Jurcisek et al. 2017), sug-
gesting this pilus acts as a type 4 secretion system that
is utilized to “inject” eDNA and DNABII proteins into the
biofilm matrix.
Biofilms and the immune system
The ECM of H. influenzae biofilms plays an integral role
in resisting the effects of the host immune system by
providing physical protection against phagocytosis and
neutrophil extracellular traps (NETs) (Juneau et al. 2011;
Langereis and Hermans 2013). In a study by Murphy
and colleagues the formation of biofilms by clinical
isolates of NTHi was found to be dependent on the pro-
duction of a 30-kDa protein identified as peroxiredox-
in–glutaredoxin (pdgX). PdgX levels were significantly
increased in NTHi biofilms compared to planktonic
growth and 44% of study participants, who were diag-
nosed with COPD, displayed considerably higher levels
of antibodies to pdgX (Murphy et al. 2005). As well as
being crucial for effective biofilm production, pdgX pro-
vides protection against oxidative stress-induced
by neutrophils invading NETs (Juneau et al. 2015). The
ability of H. influenzae biofilms to resist NETs, the pro-
duction of which is already compromised in COPD
(Pullan et al. 2015), provides ample opportunity for
H. influenzae biofilms to persist within the airways for
extended periods of time.
As well as the underlying transcriptional changes
that accompany biofilm development, production of a
robust ECM and immunoglobulin A (IgA) proteases are
key to the immunoresistance and persistence showed
by H. influenzae. IgA is a major component of the
immune system and a first-line defence mechanism of
mucosal surfaces such as the respiratory epithelium.
Increased levels of IgA have also been identified in
COPD patients compared to healthy non-smokers
(Ladjemi et al. 2015). IgA proteases produced within a
biofilm can integrate into the ECM but are primarily
found on the matrix surface where they thwart the host
immune response by cleaving human IgA, a critical first
line immunoglobulin localized in mucus membranes.
The H. influenzae genome codes for two types of IgA
proteases, igaA and igaB. All strains are able to produce
igaA and 40% of strains have igaB (Murphy et al. 2015).
There are two variants of each protease, with varying
specificities of the hinge region found in human IgA.
These proteases are variably expressed in vivo but play
an important role in bacterial survival in respiratory epi-
thelial cells (Murphy et al. 2017). Although this is yet to
be confirmed, igaB appears to play a larger role in bac-
terial survival than igaA.
In addition to stimulating biofilm formation, eDNA
binds to human b-defensin-3 (BD3), reducing its anti-
microbial properties (Jones et al. 2013). BD3 is a mem-
ber of the innate immune system and is crucial in
protecting respiratory epithelial cells from invading bac-
teria (Andresen et al. 2011). Therefore, eDNA produc-
tion by H. influenzae biofilms is essential for minimizing
the antimicrobial effects of BD3 which is upregulated in
those with COPD compared to healthy individuals
(Andresen et al. 2011).
Antibiotic tolerance
Antibiotics are a commonly used tool in the treatments
of AECOPD, however, sub-inhibitory concentrations of
b-lactams have been shown to induce H. influenzae bio-
film formation through the formation of tightly packed
biofilms of increased overall biomass, albeit containing
a reduced number of viable bacteria (Wu et al. 2014b).
This highlights the importance of carefully considering
antimicrobial options during the treatment of AECOPD
to achieve proper microbial clearance and avoid micro-
bial stimulation. The semi-dormant state of H. influenzae
biofilms display reduced metabolism and protein syn-
thesis while still maintaining the ability to modulate
responses to oxidative stress (Post et al. 2014). This
altered cell activity exacerbates the additional challenge
of limited drug diffusion through biofilm ECM compo-
nents (Singh et al. 2017). Decreased protein synthesis
also minimizes the effects of antibiotics that operate as
protein synthesis inhibitors, such as macrolides (Kanoh
and Rubin 2010).
Despite a high level of heterogeneity between bio-
films produced by clinical isolates of H. influenzae (Puig
et al. 2014), biofilm size does not influence antimicro-
bial tolerance. Reimche et al. (2016) tested the effect of
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4 antibiotics commonly used in the management of
COPD (amoxicillin, azithromycin, clarithromycin, and
ceftriaxone) on pre-formed H. influenzae biofilms and
found no correlation between biofilms of differing bio-
mass or thickness and their ability to survive treatment.
Heteroresistance is a phenomenon frequently
observed in pathogenic bacteria where subgroups of
bacteria possess a lower susceptibility to antibiotic
treatment than the general population (Nicoloff et al.
2019). Planktonic H. influenzae have been shown to dis-
play a heteroresistant phenotype against imipenem
(Cherkaoui et al. 2017). It can be expected that this tol-
erance would be strengthened within a biofilm commu-
nity and likely attributable to the differential behaviour
of biofilm integrated cells (Flemming et al. 2016). For
example, fluctuating gene expression and cell metabol-
ism can lead to the development of heteroresistant and
persisting cell phenotypes.
Biofilms and cigarette smoke
In addition to b-lactams, cigarette smoke extract (CSE)
and electronic cigarette vapour extract (ECVE) have
been shown to significantly influence H. influenzae bio-
film pathogenicity (Gilpin et al. 2019). The prevalence of
smoking within COPD populations is well documented
and prolonged tobacco use is associated with symp-
toms of progressive COPD (Liu et al. 2015). Therefore, it
is also important to understand how CSE influences
bacteria within the lungs. Due to its recent emergence
as a trend in nicotine addiction, the long-term health
impacts of electronic cigarettes remain enigmatic. For
that reason, it is imperative that studies address the
potential impact of ECVE on the COPD lung micro-
biome. Both CSE and ECVE significantly increased
H. influenzae pathogenicity in the Galleria mellonella
infection model while also causing a significant increase
in interleukin-8 (IL-8) and tumour necrosis factor a
(TNF-a). Although both extracts exhibited a stimulatory
effect on the biofilm production of a number of isolates
such as Staphylococcus aureus and Pseudomonas aerugi-
nosa, the effect on H. influenzae biofilm formation was
not significant (Gilpin et al. 2019).
Polymicrobial biofilms
Biofilms are rarely composed of a single species and
the clinical significance of these polymicrobial biofilms
is becoming increasingly recognized. The first reports
of the polymicrobial nature of biofilms can be
dated back to over three centuries ago where Antoni
van Leeuwenhoek drew illustrations representing
Streptococcus chains and Fusobacteria which he had
observed in dental plaque (Brown et al. 2019a). To date,
dental plaque remains one of the most studied and
best-characterized models of polymicrobial biofilms.
16S RNA sequencing has shown that the oral micro-
biome is similar to the lung (Bassis et al. 2015), indicat-
ing a relationship between oral and lung microbiomes.
Salivary flow and microaspiration have been identified
as major causes of bacterial migration from the oral
cavity to the lungs resulting in oral pathogens such as
Porphyromonas and Prevotella entering the lower
respiratory tract (Huffnagle et al. 2017). This migration
creates an opportunity for Porphyromonas gingivalis, a
prolific oral pathogen, to interact with other bacteria
such as Streptococcus, one of the most abundant gen-
era in COPD lungs (Zakharkina et al. 2013; Sinha et al.
2018; Millares et al. 2019); an interaction that is known
to be synergistic, promoting biofilm formation
(Simionato et al. 2006). Within a polymicrobial biofilm,
organisms are in constant communication with one
another either through direct contact or via the release
and uptake of quorum sensing molecules (Peters
et al. 2012).
As the lungs of COPD patients are home to a pleth-
ora of microorganisms (Garcia-Nu~nez et al. 2015; Wang
et al. 2016; 2017) multiple opportunities exist for patho-
gens such as H. influenzae to interact with other bac-
teria and fungi. Limited attention has, however, been
given to characterizing the interactions between
respiratory pathogens. A number of studies have
focussed on the relationship between H. influenzae and
Streptococcus pneumoniae and their impact on OM
which show a competitive link between the organisms.
For example, a study by Bair and Campagnari (2020)
reports S. pneumonia to cause a rapid decrease in viable
H. influenzae cells in dual-species biofilms after 24 h,
which supports findings by Thornton et al. (2011) who
failed to observe both species together in the same
specimen from children with OM.
In acute OM cases, when isolated in combination
with S. pneumoniae, H. influenzae was significantly more
likely to be able to produce biofilms (Vermee et al.
2019). These two pathogens have previously been
reported to modulate the expression of each other’s
virulence genes with transcription of H. influenzae T4P
significantly increased in dual-species biofilms (Cope
et al. 2011). Using a chinchilla infection model of OM, a
polymicrobial in vitro biofilm of both H. influenzae and
S. pneumoniae was able to persist in the middle ear due
to H. influenzae providing S. pneumoniae protection
against amoxicillin treatment (Murrah et al. 2015). While
previously, H. influenzae 86-028NP, a b-lactamase pro-
ducing strain, was found to protect both planktonic
and biofilm S. pneumoniae cells from amoxicillin
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(Weimer et al. 2011). b-lactamase production is
undoubtedly not the sole mechanism for antibiotic pro-
tection. Although the exact mechanisms behind this
have yet to be explored, it could be hypothesised that
the combined, increased production of bacterial ECM
prevents diffusion of antimicrobials, therefore protect-
ing both organisms.
As described above, H. influenzae has proven its abil-
ity to produce glucosyltransferases in a biofilm state
(Pang et al. 2018). As shown previously by Souza et al.
(2020), glucosyltransferases are essential, not just for
ECM production but for the proper formation of multi-
species biofilms by Streptococcus oralis and Candida
albicans. As a large number of fungal genera have been
identified in the COPD lung, future studies should
include investigations into the mechanisms of inter-
action between H. influenzae and fungi as well as other
respiratory bacterial pathogens.
Additional mechanisms of persistence
Epithelial cell invasion
NTHi utilizes a range of adhesin proteins to adhere to
the human respiratory tract. If the host fails to clear the
invading bacteria, NTHi cells can then follow one of two
paths that ultimately result in chronic colonization. The
first path leads to the bacterium being engulfed by
host respiratory epithelial cells. Secondly, the bacteria
may either remain on the epithelial cell surface or may
be bound by other host factors, such as fibronectin,
potentiating the development of a biofilm.
H. influenzae is widely regarded as an extracellular
pathogen and has shown the ability to persist in the
intercellular space between epithelial cells due to the
adhesion and invasion protein Hmw1 (Mell et al. 2016).
The ability of H. influenzae to cause the downregulation
of protocadherin 8 and cadherin 6, which are important
in epithelial cell–cell interactions, and claudin 3 and
claudin 8, which play a role in tight junction formation,
highlight other potential mechanisms that may explain
the ability of H. influenzae to invade the intercellular
space (Baddal et al. (2015). Downregulation of cytoskel-
eton and tight junction components of respiratory epi-
thelial cells, the latter of which serve to seal the
paracellular barrier, allows H. influenzae to easily and
effectively penetrate into the intercellular space.
In addition to this, evidence also shows H. influenzae
able to invade epithelial cells and persist. Ahearn et al.
(2019) identified an open reading frame (ORF) in H.
influenzae as a key virulence factor involved in cell inva-
sion. Although the product of this ORF is yet to be fully
characterized, the ability of H. influenzae cells lacking
ORF NTHI1441 to invade bronchial epithelial cells was
significantly reduced, even though cellular attachment
was observed.
As mentioned above, H. influenzae also utilizes the
P1 fimbrae, a receptor for bactericidal long-chain fatty
acids (LCFA), to bind to epithelial cells via the CEACAM-
1 receptor (Moleres et al. 2018). Once bound to
CEACAM-1, H. influenzae can then invade the respira-
tory epithelium. H. influenzae fadL (which codes for the
P1 fimbrae) null mutants are much less effective at cell
invasion. Computational analyses of >450 H. influenzae
isolate genomes showed that host factor pressure loss
of function mutations in fadL was rare with the excep-
tion of strains acquired from lung infections, which
ultimately reduces the invasion potential of H. influen-
zae but increases tolerance to bactericidal LCFA which
may benefit long term persistence.
Genetic adaptations
Mechanisms such as antigenic variation, epigenetic vari-
ation, and phase variation are also exploited by H. influ-
enzae to increase fitness and prolong persistence within
the host (Ahearn et al. 2019). In addition, where encap-
sulated H. influenzae rely on their capsule to evade the
immune system, NTHi strains have been forced to
develop alternative mechanisms. A number of genes
have been identified that are involved in protection
against complement-mediated killing (Nakamura et al.
2011). The majority of these genes are related to lipooli-
gosaccharide (LOS) synthesis. Haemophilus influenzae
LOS structure is controlled by the expression of a num-
ber of genes such as lic1A, lic2A, lic3A, lic3B, and lex2A
(Phillips et al. 2019). LOS gene expression is regulated
via phase variation, which allows for H. influenzae to
quickly adapt in response to the external environment
and therefore increasing bacterial fitness while inhabit-
ing the human respiratory tract. Expression of adhesion
genes such as hmw and hia are also controlled through
phase variation (Giufre et al. 2008; Atack et al. 2015b).
For example, the passage of H. influenzae cells through
a chinchilla model of infection selected for cells that
highly expressed the Hia protein proving that H. influen-
zae rapidly responds to its environment.
Despite playing an integral role in colonization and
persistence, surface adhesins such as Hmw1 and Hmw2
elicit a strong host immune response (Winter and
Barenkamp 2014) but this response can be moderated
by H. influenzae using phase variation. Davis et al.
(2014) reported that H. influenzae is able to repress the
expression of hmw genes due to the presence of 7 bp
tandem repeats located within the promoter region.
CRITICAL REVIEWS IN MICROBIOLOGY 199
This study also showed that the protein production
decreases as the number of tandem repeats increase.
Epigenetic variation in H. influenzae is dependent on
modA expression. H. influenzae possess over 20 varia-
tions of modA allelles (modA1–modA22). ModA genes
encode a DNA-methyltransferase, which is prone to ran-
dom on/off switching (Atack et al. 2015a). Clinical iso-
lates of H. influenzae found in the nasopharynx or inner
ear of healthy individuals and OM patients possessed
high levels of variation in the expressed modA alleles
(Atack et al. 2015a). A DmodA10H. influenzae, which
showed increased attachment to and invasion of
human bronchiole epithelial cells, highlights further
the importance of epigenetic variation in providing
H. influenzae the necessary advantages to allow survival
within the human respiratory tract (Vanwagoner et al.
2016). When “switched on” modA2 increases bacterial
susceptibility to oxidative stress and neutrophil-mediated
killing (Brockman et al. 2017). Cells expressing modA2
form biofilms with significantly greater biomass com-
pared to when this gene is “switched off.” Despite greater
biomass, the ECM of these biofilms was deficient in
eDNA (Brockman et al. 2018). It can be deduced that in
contrast to modA10, modA2 is detrimental to the survival
of H. influenzae as strains that possess modA2 are
unable to effectively produce ECM which has been
identified as a major contributor towards biofilm recal-
citrance to antimicrobial therapy and immune cell
attack (Singh et al. 2017).
H. influenzae also exhibits heterogeneity between
strains in the presence of surface antigens, the differ-
ential expression of which results in strain-specific
immune responses (Sethi et al. 2004; De Chiara et al.
2014). Contrary to phase variation, antigenic variation
in proteins such as P1, P2, and P5 occur as a result of
insertion and deletion mutations which have been
reviewed extensively elsewhere (Gilsdorf et al. 2004).
Future directions
Most of our understanding of H. influenzae biofilms and
persistence during infection still comes from OM, high-
lighting a need to address the current gaps in our
knowledge of COPD pathology. Future work in address-
ing the role of H. influenzae biofilms in COPD should
focus on developing definitive criteria for the diagnosis
of biofilms in the respiratory tract and methods that
can be used to confirm their presence. For example, a
promising new technique of real-time molecular imag-
ing could prove useful in the identification of H. influen-
zae biofilms. This method uses the environmentally
sensitive fluorophore, 7-nitrobenz-2-oxa-1,3-diazole
conjugated to polymyxin which fluoresces upon con-
tact with the lipid A component of Gram-negative bac-
teria (Akram et al. 2018). More recent studies have
shown that similar smart probes can be used to label
cell metabolites (Benson et al. 2019). Combining these
two methods may provide a crucial opportunity to
develop a method of selectively labelling molecules
associated with H. influenzae biofilms such as pgdX,
which if successful, could allow for the rapid diagnosis
of H. influenzae biofilms in the COPD lung or indeed
other conditions.
Importantly, recent studies have begun to unravel
the complex network of inter-kingdom interactions
between bacteria and fungi in lung diseases such as
cystic fibrosis and pneumonia. Despite the mycobiome
of the COPD lung being previously defined (Su et al.
2015) the interactions between fungi and bacteria in
COPD have yet to be studied in detail. Fungi such as C.
albicans and Aspergillus fumigatus are known to regu-
larly interact with bacteria causing more serious infec-
tion (Kean et al. 2017; Reece et al. 2017). Future studies
should aim to confirm if there is indeed co-association
of fungi and bacteria in the COPD lung and should
investigate if these interactions play a role in the patho-
genesis and progression of COPD.
Conclusions
As a pathogen with a major impact on the lives of COPD
patients due to chronic colonization, it is important to
understand the underlying mechanisms of persistence
employed by H. influenzae. One of the many methods of
persistence utilized by H. influenzae is the formation of
biofilms. The development of these complex microbial
communities provides numerous advantages that help
evade the host immune system and present multiple
challenges for effective antimicrobial therapies.
Despite current advances in the field of H. influenzae
biofilms, some aspects of this process particularly
around the perceived synergy of polymicrobial biofilms
remain enigmatic. Future work should aim to build
upon our understanding of H. influenzae biofilms within
COPD airways which will be aided by the development
of more refined and accurate diagnostic tools for in situ
biofilm identification. The rapid and continuous
advancement of sequencing tools should also be
exploited to further characterize the molecular mecha-
nisms behind H. influenzae biofilm formation. This
would enable the identification of key metabolites and
proteins within biofilm communities that could be uti-
lized as novel targets for new antimicrobial therapies.
The ability to prevent H. influenzae biofilm
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development or the provision of a rapid diagnosis and
effective treatment options would be an extremely
beneficial step to reduce AECOPD and help stall the
devastating progression of COPD.
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